342 related articles for article (PubMed ID: 29446615)
1. Leveraging Engineering of Cells for Drug Delivery.
Chen Z; Hu Q; Gu Z
Acc Chem Res; 2018 Mar; 51(3):668-677. PubMed ID: 29446615
[TBL] [Abstract][Full Text] [Related]
2. Bioinspired and Biomimetic Nanomedicines.
Chen Z; Wang Z; Gu Z
Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
[TBL] [Abstract][Full Text] [Related]
3. Engineering responsive polymer building blocks with host-guest molecular recognition for functional applications.
Hu J; Liu S
Acc Chem Res; 2014 Jul; 47(7):2084-95. PubMed ID: 24742049
[TBL] [Abstract][Full Text] [Related]
4. Chemical Engineering of Cell Therapy for Heart Diseases.
Li Z; Hu S; Cheng K
Acc Chem Res; 2019 Jun; 52(6):1687-1696. PubMed ID: 31125198
[TBL] [Abstract][Full Text] [Related]
5. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
6. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Engineering Platelets with PDL1 Antibodies and Iron Oxide Nanoparticles for Postsurgical Cancer Immunotherapy.
Gao Y; Chen X; Wang B; Wang S; Wang J; Ren L; Jin WK; Han H; Wang L
ACS Appl Bio Mater; 2023 Jan; 6(1):257-266. PubMed ID: 36502393
[TBL] [Abstract][Full Text] [Related]
9. Engineering unactivated platelets for targeted drug delivery.
Wu M; Shi Y; Zhao J; Kong M
Biomater Sci; 2024 Apr; 12(9):2244-2258. PubMed ID: 38482903
[TBL] [Abstract][Full Text] [Related]
10. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.
Parodi A; Molinaro R; Sushnitha M; Evangelopoulos M; Martinez JO; Arrighetti N; Corbo C; Tasciotti E
Biomaterials; 2017 Dec; 147():155-168. PubMed ID: 28946131
[TBL] [Abstract][Full Text] [Related]
11. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
Bhateria M; Rachumallu R; Singh R; Bhatta RS
Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
[TBL] [Abstract][Full Text] [Related]
12. Non-genetic engineering of cells for drug delivery and cell-based therapy.
Wang Q; Cheng H; Peng H; Zhou H; Li PY; Langer R
Adv Drug Deliv Rev; 2015 Aug; 91():125-40. PubMed ID: 25543006
[TBL] [Abstract][Full Text] [Related]
13. Antibodies and associates: Partners in targeted drug delivery.
Kennedy PJ; Oliveira C; Granja PL; Sarmento B
Pharmacol Ther; 2017 Sep; 177():129-145. PubMed ID: 28315359
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.
Fang RH; Hu CM; Luk BT; Gao W; Copp JA; Tai Y; O'Connor DE; Zhang L
Nano Lett; 2014; 14(4):2181-8. PubMed ID: 24673373
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
16. 'Smart' delivery systems for biomolecular therapeutics.
Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
[TBL] [Abstract][Full Text] [Related]
17. Coating nanoparticles with cell membranes for targeted drug delivery.
Gao W; Zhang L
J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
[TBL] [Abstract][Full Text] [Related]
18. Smart blood cell and microvesicle-based Trojan horse drug delivery: Merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine.
Wu YW; Goubran H; Seghatchian J; Burnouf T
Transfus Apher Sci; 2016 Apr; 54(2):309-18. PubMed ID: 27179926
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
[TBL] [Abstract][Full Text] [Related]
20. Recognition Sites for Cancer-targeting Drug Delivery Systems.
Guan S; Zhang Q; Bao J; Hu R; Czech T; Tang J
Curr Drug Metab; 2019; 20(10):815-834. PubMed ID: 31580248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
